CVS
41
2
LH
48
2
PM
56
2
LOW
45
2
HBAN
82
2
COST
53
5
A
46
2
MMC
60
3
PSA
37
2
MO
57
4
CMI
73
-2
AIV
48
4
EXPD
48
-2
GRMN
40
3
AAPL
55
2
GT
39
2
DIS
72
2
EXC
53
3
F
58
2
AN
52
2
CVS
41
2
LH
48
2
PM
56
2
LOW
45
2
HBAN
82
2
COST
53
5
A
46
2
MMC
60
3
PSA
37
2
MO
57
4
CMI
73
-2
AIV
48
4
EXPD
48
-2
GRMN
40
3
AAPL
55
2
GT
39
2
DIS
72
2
EXC
53
3
F
58
2
AN
52
2
Financhill
Back

Aldeyra Therapeutics, Inc. 10K Form

Buy
62

ALDX
Aldeyra Therapeutics, Inc.

Last Price:
$5.29
Seasonality Move:
10.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALDX News And Ratings

See the #1 stock for the next 7 days that we like better than ALDX

ALDX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-7M
Price / Cash Flow: 0
Annual Sales: $0.82
Price / Book: 6.46

Profitability

EPS (TTM): -0.72180
Net Income (TTM): $-43.2M
Gross Margin: $-249.6K
Return on Equity: -66.61%
Return on Assets: -45.19%

Aldeyra Therapeutics, Inc. Earnings Forecast

Key Aldeyra Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 14 years have been positive in 8 years.

Aldeyra Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALDX
CUSIP: 01438T
Website: aldeyra.com

Debt

Debt-to-Equity Ratio: 0.32
Current Ratio: 2.68
Quick Ratio: 2.64

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 16.14

ALDX Technical Analysis vs Fundamental Analysis

Buy
62
Aldeyra Therapeutics, Inc. (ALDX) is a Buy

Is Aldeyra Therapeutics, Inc. a Buy or a Sell?